The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC): CALGB 80802 (Alliance).
 
Ghassan K. Abou-Alfa
No Relationships to Disclose
 
Donna Niedzwieski
No Relationships to Disclose
 
Jennifer J. Knox
No Relationships to Disclose
 
Andreas Kaubisch
No Relationships to Disclose
 
James Posey
No Relationships to Disclose
 
Benjamin R. Tan
No Relationships to Disclose
 
Petr Kavan
No Relationships to Disclose
 
Rakesh Goel
No Relationships to Disclose
 
Philip Edward Lammers
No Relationships to Disclose
 
Tanios S. Bekaii-Saab
No Relationships to Disclose
 
Vincent Channing Tam
No Relationships to Disclose
 
Lakshmi Rajdev
No Relationships to Disclose
 
Robin Kate Kelley
No Relationships to Disclose
 
Abby B. Siegel
No Relationships to Disclose
 
Jennifer Balletti
No Relationships to Disclose
 
James J. Harding
No Relationships to Disclose
 
Lawrence HOWARD Schwartz
No Relationships to Disclose
 
Richard M. Goldberg
No Relationships to Disclose
 
Monica M. Bertagnolli
No Relationships to Disclose
 
Alan P. Venook
No Relationships to Disclose